Details of the Drug Formulaction

General Information of Drug Formulation (ID: F15992)

• Formulation Name: Ondansetron 4 mg tablet
• Company: Kaiser Foundation Hospitals; RemedyRepack

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Ondansetron	(DMOTQ1I)	Chemotherapy-induced nausea	MD90	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Carmellose sodium	(E00625)	Not Available	Disintegrant
Lactose monohydrate	(E00393)	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	(E00208)	11177	lubricant
Triacetin	(E00080)	5541	Humectant; Plasticizing agent; Solvent